

Back to All Services
Our Services
Healthcare Strategy & Consulting
At Medicys, we partner with leading global strategy and consulting firms who advise healthcare business leaders on their most critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers & acquisitions. Typical projects in this space will focus on:
- Market Sizing & Value Proposition development
- Digital Marketing & Sales Strategy
- End-to-End Patient Experience Strategy
- Asset identification and acquisition
- Telehealth implementation
- Portfolio management and prioritisation
- Patient Support Program (PSP) strategy
- Strategic positioning
- Competitive analysis
In practice, we do this through providing primary research services to provide the market understanding and evidence needed to support the analysis and strategic recommendations of the consulting team.
We can connect healthcare consultants with the respondents they need, be they health care professionals, KOLs and/or local, regional or national level payers, patients, patient organisations or other relevant targets to inform their strategy planning.
The properly sourced and well vetted research participants we can access are key to produce actionable insight.
Related Work
See all Work


healthcare strategy and consulting
+5
Emergency medicine, infectious diseases, intensive care / critical care medicine, infection control specialists, laboratory managers
To understand HCPs views on antimicrobial resistance


healthcare strategy and consulting
Gather insight into how a biologic indicated for mild to moderate psoriasis would be assessed and managed


healthcare strategy and consulting
Minimally Invasive Procedures
To understand referral patterns and factors influencing referral decisions, and to Identify the most effective strategies that will help strengthen the connection between GPs and hospitals or specialists to facilitate referrals for minimally invasive procedures (MIPs).


healthcare strategy and consulting
Multiple Myeloma
To understand current treatment decisions and practices in Multiple Myeloma, familiarity with the future entrants into the market (including discussing and reviewing hypothetical future product profiles) and how they may be positioned for optimal treatment of Multiple Myeloma in the future.
See More Services
Request a quote